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 INTRODUCTION
IgA dominant glomerulonephritis (GN) associated to staphylococcal 
infection while rare is an increasingly recognized morphologic variant 
of infectious GN, in which there is glomerular deposition of IgA, either 
dominant or co -dominant. This entity has been described mainly 
through minor case reports.1 Koyama et al first described it in 1995, 
in 10 patients with methicillin -resistant Staphylococcus aureus (MRSA) 
infection.2 Methicillin-sensitive Staphylococcus aureus (MSSA) has 
also been reported in 18% of patients.2
It is thought that bacterial superantigens, such as enterotoxins (C 
and A) and toxic shock syndrome toxin act as activators of the immune 
system, leading to the formation of immunocomplexes.3 By binding 
to major histocompatibility class II molecules they stimulate T cells 
and cytocine production, inducing polyclonal activation of IgG and 
IgA.2 Koyama et al also suggested that a probable adhesion factor, 
defined as Staphylococcus aureus cell envelope antigen, has a patho-
genic induction role since it has been noticed in patients with IgA 
nephropathy (IgAN) and IgA dominant GN associated to staphylococcal 
infection but not in other immunocomplex glomerulonephritis.4
IgA dominant GN associated to staphylococcal infection is most 
frequently seen in elderly male patients and over half are diabetic.5 
Staphylococcus has become 3 times more common than Streptococcus 
as the causative agent of infectious glomerulonephritis in the 
elderly.6
The origin of infection is highly variable, with the most frequent 
skin, deep -seated abscesses, surgical wounds, lung, joint and heart.1,5 
Features backing IgA dominant GN associated to staphylococcal infec-
tion include initial presentation at older age, diabetes, acute renal 
failure, intercurrent culture documenting staphylococcal infection, 
hypocomplementemia, diffuse glomerular endocapillary hypercellular-
ity on light microscopy (LM), dominant immunofluorescent (IF) staining 
for C3 over IgA and presence of subepithelial humps on electron 
microscopy (EM).7,8 Immunocomplex mediated glomerulonephritis 
and IgAN have been described as rare entities associated to seronega-
tive spondyloarthropathies. Concurrently reactive arthritis and glo-
merulonephritis are rare among the adult population and often under-
diagnosed. Different infectious agents can trigger reactive arthritis, 
usually affecting people in their second to fourth decades of life and 
occurs weeks following genitourinary (male to female 9:1) or enteric 
(1:1) infections.9 Most of these patients respond to non -steroid anti-
-inflammatory drugs while steroids are effective in peripheral arthritis 
and aggressive presentation cases.
Regarding the emerging importance of a new entity such as IgA 
dominant GN associated to Staphylococcus aureus infection we present 
a patient who had an overlooked MSSA infection history with rapidly 
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progressive renal dysfunction associated to a classical histological pat-
tern of IgA dominance.
 CASE REPORT
A 63 -year -old caucasian man was referred to our emergency depart-
ment due to routine laboratory finding of a stage II acute kidney injury 
(AKI)10. His medical background was marked by a history of hyperten-
sion, diagnosis of pre -diabetes 8 years ago and a recent hospital admis-
sion dating back 3 months with a MSSA bacteremia due to prostatitis. 
At that time, he presented normal kidney function and no proteinuria. 
His history was otherwise unremarkable as he had no relevant family 
history and was currently on no chronic medication.
One month before emergency admission the patient referred a 
prior eight -kilogram weight gain and starting of progressive peripheral 
edemas, foamy urine and polyarticular pain in small and medium 
joints with an inflammatory pattern. Apart from the edema, his physi-
cal examination was unremarkable, namely for afebrile and normo-
tensive presentations and no skin rash was noticed. Laboratory findings 
had already shown altered renal function with serum creatinine (sCr) 
of 1.8mg/dL, hypercholesterolemia and hypertriglyceridemia. Urinaly-
sis was normal, with no proteinuria or hematuria. A laboratory re -eval-
uation was requested within a one -month period that evidenced an 
abrupt rise in sCr motivating emergency department referral.
On admission to the emergency department, laboratory tests evi-
denced a rapidly progressive renal failure, with sCr of 3.62mg/dL as 
opposed to a 3 -months earlier basal level of 0.8mg/dL and 1.8mg/dL 
one month before. As for urinalysis, an active sediment was now 
evident showing 3+ erythrocyturia with a nephrotic range proteinuria 
(4+ with a urinary protein/creatinine ratio of 23mg/mg) and a serum 
albumin of 22 mg/dL. Subsequent investigation showed no abnormal 
diagnostic imaging findings on renal ultrasound and a negative serol-
ogy for viral hepatitis, HIV and VDRL. Immunological markers (anti-
nuclear antibody (ANA) (IIF (Indirect Immunofluorescence) and CLIA 
(chemiluminescent immunoassay), anti -double -stranded DNA (anti-
-dsDNA) (IFI and CLIA), antineutrophil cytoplasmic antibody (ANCA) 
(CLIA) were normal. No complement changes were detected and his 
serum protein electrophoresis showed low albumin, elevated alpha 
2 and beta region and decreased gamma region, resembling a nephrot-
ic pattern. Cryoglobulinemia was not screened. Diabetic retinopathy 
was excluded to assess microvascular diabetic involvement. At this 
time salt restriction, inhibitor enzyme angiotensin -converting, loop 
diuretics, statin and low molecular weight heparin (LMWH) were initi-
ated followed by a kidney biopsy on day 3 (with temporary suspension 
of LMWH) due to a clinical course of rapidly progressive glomerulo-
nephritis. The biopsy showed segmental endocapillary proliferation 
(Figure 1) and fibrinoid necrosis. Extensive tubular necrosis was noted. 
IF revealed dominant IgA segmental deposition (Figure 2), associated 
to C3 and lambda in minor distribution. Kappa light chain was absent. 
EM was not performed. This histopathological finding associated to 
his clinical background of diabetes, documented prior 10 -week infec-
tion of MSSA bacteremia and an aggressive presentation led to the 
suspicion of IgAdominantGN associated to staphylococcal infection.
Due to his highly active inflammatory histopathological background 
and no signs of active infection, we opted for a trial of 1mg/kg/day 
prednisone (60mg) for 8 weeks, then tapered off over a 9 -month 
period. Gradual improvement of his renal function was documented, 
and after 52 weeks his sCr was 1.8mg/dL (maximum sCr level 4.84mg/
dL) (Table I). Though, following steroids withdrawal and apparent renal 
recovery with no signs of clinical activity (lower level of hematuria 
and total remission of proteinuria and normal complementemia), the 
arthralgia relapsed following the same previous pattern but with a 
Figure 2
Anti -IgA immunofluorescence showing granular glomerular capillary wall and 
mesangial staining for IgA

Figure 1
Glomerulus showing mesangial and endocapillary proliferation and infiltrating 
leucocytes. Periodic acid -Schiff, ×400

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higher pain intensity (numeric pain scale 7/10) and highly debilitating, 
raising the suspicion of post infectious arthritis. The patient responded 
only after the reintroduction of low dose prednisone and 
hydroxychloroquine.
 DISCUSSION
This case highlights the often misdiagnosed IgA dominant GN asso-
ciated to staphylococcal infection that mimics IgAN mainly in cases 
where infection is either overlooked or not apparent. In this way, IgA 
dominant GN associated to staphylococcus infection represents a chal-
lenge in our clinical practice.
Our patient’s clinical, laboratorial and histological presentation 
follows literature findings. In some of the major studies6 -8 the diagnosis 
is made if at least two of the following criteria is satisfied in a patient 
with clinical or laboratory evidence of staphylococcal infection and 
onset of glomerulonephritis usually with endocapillary proliferation 
and exudative glomerulonephritis on LM (observed in our patient), 
C3 dominant/co -dominant glomerular staining or IgA -dominant or 
co -dominant disease together with intense C3 staining on IF micros-
copy (observed in our patient) and hump -shaped subepithelial deposits 
on EM, paired with hypocomplementemia (primarily C3).
Multiple features support IgA dominant GN over IgAN namely inter-
current culture documented staphylococcal infection, older age, history 
of diabetes mellitus and acute renal failure. The majority of patients 
present with AKI with concomitant microscopic hematuria in 83% and 
nephrotic range in 50% of cases.1 As in this case, infection was not 
apparent at the time of onset of the glomerulonephritis, as is seen in 
25% of the cases described in literature.1 Although staphylococcal infec-
tion can be consistent with renal disease, glomerulonephritis can occur 
within a ten week period, normally between one to sixteen weeks.1,11,12 
Pathological features such as endocapillary proliferation on LM and IgA 
co dominant deposition in IF also sustain this hypothesis. Endocapillary 
proliferative and exudative GN are reported in 63% of the cases.5 IF 
analysis shows a dominant granular IgA glomerular staining with or 
without a staining for IgG and/or IgM. Staining for C3 is also seen in the 
majority of cases (normally stronger than IgA). EM was not performed 
in our patient; nevertheless a low frequency of subepithelial humps 
compared with poststreptococcal glomerulonephritis has been described 
particularly in cases in which infection is subtle or not clinically present 
as in this case.13 Although hypocomplementemia may be an important 
clue for diagnosis and is present in the majority of cases, complement 
levels were not consistently depressed in all case reports. 2,14 -15
It is extremely unlikely in this case that IgA dominant GN represents 
an exacerbation of a pre -existing primary IgAN as most patients are 
older, have no prior history of glomerulonephritis or proliferative his-
tological findings.5
Henoch -Schonlein purpura nephritis (HSPN) associated to staphy-
lococcus infection has also been reported in literature, making 
Table I
Laboratorial data showing patient’s evolution
Variable Reference range
1 month 
before 
hospital 
admission
On hospital 
admission
Following  
1 week 
investigation
Day 5
Prednisolone 
(60mg)
Day 10
Prednisolone 
(60mg)
2 months
Prednisolone 
(50mg)
4 months
Prednisolone 
(30mg)
9 months
Prednisolone 
(5mg)
12 months
Prednisolone 
(0mg)
Blood
Hemoglobin (g/dl) 13.0-18.0 13.4 13.9 12.2 12.4 12.4 9.4 9.2 10.4 10.2
White-cell count (per mm3) 4500 -11,000 7,700 9,900 7,900 14,600 24,300 15,700 11,800 10,100 12,300
Platelet count (per mm3) 150,000–
450,000 
269,000 239,000 302,000 291,000 249,000 178,000 184,000 232,000 272,000
Erythrocyte-sedimentation 
rate (mm/hr) 
0 -20 – – 80 59 52 54 35 69 74
C -reactive protein (mg/dL) <6.10 – 0 -21 2.76 0.61 0.69 0.44 0.40 6.66 16.91
Urea nitrogen (mg/dl) 8.0 -50.0 45 73 55 207 137 139.9 174.7 150.2 129.0
Creatinine (mg/dL) 0.7 -1.20 1.8 3.62 3.4 4.84 2.96 1.87 2.07 2.02 1.86
Total protein (g/dl) 60.0 -80,0 46.4 46.2 – 41.2 38.4 42.8 48.7 60.3 61.7
Albumin (mg/dl) 35.0 -48.0 – 22 19 21 21 25.8 29.9 39.3 40
Total Cholesterol (mg/dL) <200 – – 431 – – 338 215 180 147
Triglyceride (mg/dL) <150 – – 571 – – 717 367 332 393
C3 90.0 -180.0 – – – 142 120 – 104 142 –
Urine
Protein negative negative 4+ 1000 mg/dL 400 mg/dL 400 mg/dL 1000 mg/dL – 100 mg/dL
Red cells negative negative 3+ 114.3/ µl 45.47/ µl 291.41/ µl 45.47/ µl – 45.47/ µl 6.11/ µl
Leukocytes 0 -2 negative 0 12.3/ µl 4.2/ µl 4.01/ µl 0/ µl – 25.7/ µl 3.3/ µl
Ratio of total protein (in 
mg) to creatinine (in mg) 
<0.2 negative – 23.3 13 17.3 10.1 3.6 0.68 0.4
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differential diagnosis with IgA dominant GN associated to staphylococ-
cus infection a challenge in clinical practice.16,17 Their histopathologies 
are similar, presenting with proliferative glomerulonephritis and there 
is also renal involvement characterized by hematuria and proteinuria 
and in addition to being a distinct classical diagnosis in childhood, 
adult occurrence has also been reported.18The diagnosis of PSH is 
criteria -based, supported by The European League Against Rheuma-
tism (EULAR), the Paediatric, Rheumatology International Trials Organi-
zation (PRINTO) and Paediatric Rheumatology European Society 
(PRES).19,20 One study has reviewed these criteria and found appli-
cability to adults with a diagnostic sensitivity of 99.2% and a specificity 
of 86%.21 Applying this diagnostic criteria helps us distinguish two 
identical histopathological entities, excluding HSPN due to the lack of 
such mandatory criteria as purpura or petechiae with lower limb pre-
dominance. Although our patient presented with proliferative glo-
merulonephritis with IgA deposits and has renal involvement such as 
proteinuria and hematuria he did not meet other minor criteria such 
as the diffuse acute abdominal pain or other gastrointestinal mani-
festations and did not present with the typical transient oligoarticular 
arthritis of large joints. Per definition, dominant IgA deposits are 
observed in the mesangium of all glomeruli; however in HSPN as a 
vascular disease, capillary wall staining is more frequently found and 
may predominate on mesangial IgA22, which was not verified in our 
patient.
Treatment is still not consistent in the literature. The standard 
treatment consists of completely eradicating the staphylococcal infec-
tion with an appropriate course of wisely selected antibiotics. Unfor-
tunately, it is known that steroid therapy in staphylococcus related 
glomerulonephritis can precipitate severe staphylococcal sepsis and 
even death. Given the highly inflammatory histopathological pattern, 
rapid progression of renal disease and no active infection status, we 
opted for a steroids trial with what we considered reasonably good 
results. High dose steroids are generally reserved for aggressive forms 
of IgA nephritis and may be used for a postinfectious phase in which 
there is a clearly significant inflammatory pattern.15 The poor prognosis 
and lower recovery rate associated with IgAdominantGN is attributed 
to the associated comorbidities. Prognosis is guarded with less than 
a fifth of patients fully recovering renal function.5 The prognosis of 
IgAdominantGN is less favorable than typical post infectious glomeru-
lonephritis.6,14 Hypertension, diabetes mellitus and fibrosis on kidney 
biopsy seem related to poor prognosis and deterioration of renal 
function.1,4
In addition, this current case brings to the discussion the concept 
of an immune mediated response resulting from slow allocation bac-
teria that led to different organ lesions in different temporal settings. 
This may also indicate a defective first -line defense (probably due to 
a state of chronic inflammation) in the patient’s developing arthritis 
and glomerulonephritis that allowed the bacterial antigens to reach 
the synovium and glomeruli respectively. Finally, this case alerts clini-
cians to consider the diagnosis of IgAdominantGN when renal injury 
occurs and there is a previous isolation of MSSA, especially when 
immunosuppression states, such as diabetes mellitus, are present. 
Prompt treatment is warranted and may lead to full progressive recov-
ery of renal function.
Disclosure of potential conflicts of interest: none declared.
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